Solid lipid nanoparticles (SLNs) are nanocarriers developed as substitute colloidal drug
delivery systems parallel to liposomes, lipid emulsions, polymeric nanoparticles, and so …

Transdermal drug delivery refers to a means of delivering drugs through the surface of the
skin for local or systemic treatment. The drug functions after absorption through the skin into …

Nanocarriers can deliver drugs to specific organs or cells, potentially bridging the gap
between a drug's function and its interaction with biological systems such as human …

Lipid-based drug delivery systems has become a popular choice for oral delivery of
lipophilic drugs with dissolution rate limited oral absorption. Lipids are known to enhance …

The respiratory system, especially the lung, is the key site of pathological injury induced by
SARS-CoV-2 infection. Given the low feasibility of targeted delivery of antibodies into the …

The concept of drug delivery systems as a magic bullet for the delivery of bioactive
compounds has emerged as a promising approach in the treatment of different diseases …

Various eco-friendly techniques are being researched for synthesizing ZnO-NPs, known for
their bioactivity. This study aimed at biosynthesizing ZnO-NPs using Streptomyces …

The interest in extracellular vesicles (EVs) increased during the last decade. It is now
established that these vesicles play a role in the pathogenesis of central nervous system …

The lipid-based colloidal carriers, such as nanostructured lipid carriers (NLCs), solid lipid
nanoparticles (SLNs), nanocapsules, liposomes, and microemulsion, are the latest and …

Catechol-O-methyltransferase inhibitors (iCOMT), such as entacapone, have been
successfully employed to treat tremor-related symptoms of Parkinson's disease. However …